PEG-Intron - Monotherapy

Pegylated Interferon plus Ribavirin in Patients with HBV-HCV Dual Infection  - 4/27/07

Superior Results Using Antiviral Agents Before Pegylated Interferon to Treat Hepatitis B 1/26/07

PegIntron for Treatment of Hepatitis B Patients Who Did Not Respond to Prior Therapy 1/09/07

Treatment with PegInterferon Alfa-2b: HBsAg Loss Is Associated with HBV Genotype - 2/24/06

Predictive Factors for Dose Reduction and Treatment Discontinuation of Peginterferon Alfa-2b in the Treatment of Chronic Hepatitis B - 5/13/05

The Lancet Publishes First Study Showing Peginterferon Alfa-2b Is Effective As Monotherapy In the Treatment of Chronic Hepatitis B: Press Announcement from the Erasmus Medical Center  - 01/07/05

Pegylated Interferon Alfa-2b Alone or in Combination with Lamivudine for HBeAg-positive Chronic Hepatitis B: Results of a Randomised Trial - 01/07/05

Peginterferon Alone and in Combination with Lamivudine Improves Liver Histology in Chronic HBV Patients, but Does Not Reduce Fibrosis - 04/30/04

Combination Therapy with Peginterferon Alfa-2b (PEG-IFN) and Lamivudine Is More Effective Than PEG-IFN Alone, But Does Not Result in Greater Sustained Response Rates - 04/30/04

Among Children Who Were Nonresponders to Interferon, One Year Treatment with Lamivudine Provided Benefits - 04/30/04

Peginterferon Alfa-2b (PEG-Intron) Monotherapy and in Combination with Lamivudine Improves Liver Histology in Chronic HBV Patients but Does Not Significantly Improve Fibrosis - 04/21/04